Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
Neuropathology : Official Journal of the Japanese Society of Neuropathology|January 29, 2011
Induction of autophagy in temozolomide treated malignant gliomasManabu Natsumeda, Hiroshi Aoki, Hiroaki Miyahara, et al.Journal of Neurosurgery|October 22, 2003
Induction of an antitumor immunological response by an intratumoral injection of dendritic cells pulsed with genetically engineered Semliki Forest virus to produce interleukin-18 combined with the systemic administration of interleukin-12Ryuya Yamanaka, Naoto Tsuchiya, Naoki Yajima, et al.Cancer Science|June 11, 2013
Gene expression signature-based prognostic risk score in patients with glioblastomaAtsushi Kawaguchi, Naoki Yajima, Naoto Tsuchiya, et al.International Journal of Oncology|October 8, 2005
Isolation and characterization of an N-linked oligosaccharide that is increased in glioblastoma tissue and cell linesNaoto Tsuchiya, Ryuya Yamanaka, Naoki Yajima, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2005
Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trialRyuya Yamanaka, Junpei Homma, Naoki Yajima, et al.International Journal of Oncology|September 10, 2003
Selection of surrogate marker genes in primary central nervous system lymphomas for radio-chemotherapy by DNA array analysis of gene expression profilesRyuya Yamanaka, Shigeru Akutagawa, Fumiko Taguchi, et al.Leukemia & Lymphoma|June 20, 2007
Salvage therapy and late neurotoxicity in patients with recurrent primary CNS lymphoma treated with a modified ProMACE-MOPP hybrid regimenRyuya Yamanaka, Yoshikatsu Shinbo, Masakazu Sano, et al.Japanese Journal of Clinical Oncology|April 17, 2008
Results of treatment of 112 cases of primary CNS lymphomaRyuya Yamanaka, Ken Morii, Yoshikatsu Shinbo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
Immunologic evaluation of personalized peptide vaccination for patients with advanced malignant gliomaNaoki Yajima, Ryuya Yamanaka, Takashi Mine, et al.Japanese Journal of Clinical Oncology|February 9, 2017
Long-term survivors of primary central nervous system lymphomaRyuya Yamanaka, Ken Morii, Masakazu Sano, et al.Pageof 4